138 related articles for article (PubMed ID: 16775896)
1. Use of magnetic navigation to facilitate transcatheter alcohol septal ablation for hypertrophic obstructive cardiomyopathy.
Bach RG; Leach C; Milov SA; Lindsay BD
J Invasive Cardiol; 2006 Jun; 18(6):E176-8. PubMed ID: 16775896
[TBL] [Abstract][Full Text] [Related]
2. Initial experience with alcohol septal ablation using a novel magnetic navigation system.
Buergler JM; Alam S; Spencer W; Kleiman NS; Melendez Y; Franklin J; Nagueh SF
J Interv Cardiol; 2007 Dec; 20(6):559-63. PubMed ID: 18042061
[TBL] [Abstract][Full Text] [Related]
3. Percutaneous transluminal septal artery ablation using polyvinyl alcohol foam particles for septal hypertrophy in patients with hypertrophic obstructive cardiomyopathy: acute and 3-year outcomes.
Gross CM; Schulz-Menger J; Krämer J; Siegel I; Pilz B; Waigand J; Friedrich MG; Uhlich F; Dietz R
J Endovasc Ther; 2004 Dec; 11(6):705-11. PubMed ID: 15615561
[TBL] [Abstract][Full Text] [Related]
4. [Effectivness of transcatheter alcohol septal ablation in treatment of obstructive hypertrophic cardiomyopathy].
Chernov SA; Kucherov VV; Fursov AN; Zakharova EG; Gaĭdukov AV; Liapkova NB; Korneev NV; Pestovskaia OR
Voen Med Zh; 2009 Feb; 330(2):28-35. PubMed ID: 19351021
[No Abstract] [Full Text] [Related]
5. Role of percutaneous septal ablation in hypertrophic obstructive cardiomyopathy.
Kimmelstiel CD; Maron BJ
Circulation; 2004 Feb; 109(4):452-6. PubMed ID: 14757682
[No Abstract] [Full Text] [Related]
6. [Percutaneous transluminal septal ablation with ethanol in hypertrophic obstructive cardiomyopathy: a case report].
Sakakibara M; Abe S; Fusegawa Y; Nakajima T; Iwata O; Goto S; Shiina Y; Handa S
J Cardiol; 1999 Jul; 34(1):35-40. PubMed ID: 10422624
[TBL] [Abstract][Full Text] [Related]
7. Descending septal branch of right coronary artery: Rare, but important in hypertrophic cardiomyopathy.
Chatterjee A; Oates ET; Leesar MA; Alli OO
Cardiovasc Revasc Med; 2017 Sep; 18(6S1):23-25. PubMed ID: 28365416
[TBL] [Abstract][Full Text] [Related]
8. Percutaneous transseptal myocardial ablation with wire (PTSAW): a new technique.
Trehan V; Mukhopadhyay S; Rangasetty UC
J Invasive Cardiol; 2004 Apr; 16(4):204-6. PubMed ID: 15152148
[TBL] [Abstract][Full Text] [Related]
9. Outcome of alcohol septal ablation for obstructive hypertrophic cardiomyopathy.
Sorajja P; Valeti U; Nishimura RA; Ommen SR; Rihal CS; Gersh BJ; Hodge DO; Schaff HV; Holmes DR
Circulation; 2008 Jul; 118(2):131-9. PubMed ID: 18591440
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous trans-apex intra-septal radiofrequency ablation of hypertrophic cardiomyopathy.
Zuo L; Sun C; Yang J; Liu B; Zhou M; Guo R; Yu S; Ge J; Xiong L; Liu L
Minim Invasive Ther Allied Technol; 2018 Apr; 27(2):97-100. PubMed ID: 28949276
[TBL] [Abstract][Full Text] [Related]
11. Acute decompensation of hypertrophic obstructive cardiomyopathy secondary to A-V disassociation: successful treatment with a combination of alcohol septal ablation and permanent pacemaker.
Rohatgi S; Wiegers SE; Hsia H; Herling I; Herrmann HC
J Interv Cardiol; 2005 Oct; 18(5):401-6. PubMed ID: 16202120
[TBL] [Abstract][Full Text] [Related]
12. Apical infarct via septal collateralization complicating transluminal alcohol septal ablation for hypertrophic cardiomyopathy.
Parham WA; Kern MJ
Catheter Cardiovasc Interv; 2003 Oct; 60(2):208-11. PubMed ID: 14517926
[No Abstract] [Full Text] [Related]
13. Nuclear magnetic resonance for the assessment of the effects of alcohol septal ablation in hypertrophic cardiomyopathy.
Kornacewicz-Jach Z; Wojtarowicz A; Goos H; Schulz-Menger J; Goracy J; Płońska E; Przybycień K
Kardiol Pol; 2004 Nov; 61(11):461-7. PubMed ID: 15883594
[TBL] [Abstract][Full Text] [Related]
14. Letter by ElBardissi regarding article, "Outcome of alcohol septal ablation for obstructive hypertrophic cardiomyopathy".
Elbardissi AW
Circulation; 2009 Feb; 119(4):e187; author reply e188. PubMed ID: 19188515
[No Abstract] [Full Text] [Related]
15. Alcohol septal ablation for symptomatic hypertrophic obstructive cardiomyopathy in patients with prior coronary revascularization.
Khouzam RN; Naidu SS
J Invasive Cardiol; 2010 Dec; 22(12):E220-4. PubMed ID: 21127375
[TBL] [Abstract][Full Text] [Related]
16. Comparison of successful and failed alcohol septal ablations for obstructive hypertrophic cardiomyopathy.
Mayer SA; Anwar A; Grayburn PA
Am J Cardiol; 2003 Jul; 92(2):241-2. PubMed ID: 12860237
[No Abstract] [Full Text] [Related]
17. New approach to septal ablation: glue (cyanoacrylate) septal ablation.
Oto A; Aytemir K; Deniz A
Catheter Cardiovasc Interv; 2007 Jun; 69(7):1021-5. PubMed ID: 17525960
[TBL] [Abstract][Full Text] [Related]
18. Non-surgical septal myocardial reduction by coil embolization for hypertrophic obstructive cardiomyopathy: early and 6 months follow-up.
Durand E; Mousseaux E; Coste P; Pillière R; Dubourg O; Trinquart L; Chatellier G; Hagège A; Desnos M; Lafont A
Eur Heart J; 2008 Feb; 29(3):348-55. PubMed ID: 18203702
[TBL] [Abstract][Full Text] [Related]
19. Successful coronary stenting of the left anterior descending artery at the branching site of the targeted septal perforator immediately after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy.
Honda T; Sakamoto T; Miyamoto S; Sugiyama S; Yoshimura M; Ogawa H
Intern Med; 2005 Jul; 44(7):722-6. PubMed ID: 16093594
[TBL] [Abstract][Full Text] [Related]
20. Percutaneous transluminal septal myocardial ablation performed via the right coronary artery rather than the left anterior descending artery for the treatment of hypertrophic obstructive cardiomyopathy.
Takagi K; Mukawa H; Morishima I; Uesugi M; Okumura Y; Tsuboi H; Sone T
Int J Cardiol; 2013 Jan; 162(3):e51-2. PubMed ID: 22981456
[No Abstract] [Full Text] [Related]
[Next] [New Search]
